entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 21:27:53 - browse：72

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

explore

WSS

Medicare isn't yet testing food as medicine

6 solutions to address cancer drug shortages and others

Congress extends some pandemic preparedness programs

Medicare Advantage isn’t working — for anyone

Elisabeth Bik tackles the widespread issue of research misconduct

Change Healthcare cyberattack shows risk of industry consolidation

focus

entertainment

entertainment

Cancer drug shortages should be causing more outrage

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Wildfire smoke exposes gaps in outdoor worker protections

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Medicare proposal to cover medical devices draws a mixed reaction

The stability of $0 premiums in Medicare Advantage

Medical records are filled with copy

What will Novo Nordisk's VC do with its influx of cash?

Medical records are filled with copy

Cholera vaccine supplies dangerously low, outbreaks surging

entertainment

Study points to new risk in gene therapy death of Terry Horgan

Medicare Advantage isn’t working — for anyone

Lawsuit highlights wrinkle for disputes over surprise medical bills

Will an HIV vaccine ever be a reality?

Color Health wants to make cancer screenings convenient

Neuroscience renaissance leads to new crop of psychiatric drugs

hotspot

explore

hotspot

explore